Search results
A Monoclonal Antibody Could Help Fight Malaria
Medscape· 7 hours agoMalaria is the world's leading parasite-related endemic disease. Infections caused by Plasmodium falciparum, the deadly species, are the most common and...
AbbVie and FutureGen link on inflammatory bowel disease
Pharmaceutical Technology via Yahoo Finance· 4 hours agoThe asset is currently in the preclinical development phase. A fully human monoclonal antibody,...
China's quantity and quality of innovate drugs joins global lead
China Daily· 1 hour agoChina has approved 82 innovative drugs and 138 innovative medical devices since 2022, a health official said on Friday. Huang Guo, deputy director of the National Medical Products Administration ...
Alzheimer’s Disease Drug Donanemab Gets Unanimous Backing From FDA Expert Panel
Forbes· 3 days agoA Food and Drug Administration expert panel of advisors voted 11-0 yesterday to recommend that the...
Eli Lilly's Alzheimer's Drug Gains Unanimous FDA Panel Backing
Verywell Health via Yahoo News· 3 days agoAn FDA advisory panel endorsed donanemab, Eli Lilly’s monoclonal antibody drug designed to slow the...
“Inoculation” to Resist Misinformation
Journal of the American Medical Association· 3 days agoThe global spread of false and misleading information poses serious threats to public health by promoting vaccine hesitancy, non–evidence-based therapies (eg, “natural” remedies), and even the ...
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 4 days agoEli Lilly & Co.'s shares climbed in early US trading after its experimental drug for Alzheimer's...
A Guide to Managing COVID This Summer
New York Times· 2 days agoHere’s what to know about symptoms, testing and treatment. As new variants of the coronavirus continue to gain traction, doctors and researchers are...
Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 (TOPO1i anti-CLDN18.2 ADC) as...
Yucaipa News Mirror· 2 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology ...
Is 'Difficult-to-Treat' RA a Lost Cause?
MedPage Today· 1 day agoRheumatologists are still struggling with what to do when multiple state-of-the-art treatments have failed to bring rheumatoid arthritis (RA) under...
